Bayer Pharma Head Tapped to Replace Oxford GlycoSciences CEO | GenomeWeb

NEW YORK, May 24 - Oxford GlycoSciences today said it has hired David Ebsworth to take over the CEO post after Michael Kranda leaves on July 11.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.